2024年6月27日 · Benztropine – We suggest a dose of 1 to 2 mg IM or IV acutely followed by 1 to 2 mg orally daily. Milder cases may be treated with oral benztropine 1 to 2 mg once or twice daily. The emergence of a dystonia should lead to reevaluation of the patient's antipsychotic regimen.

Physicians have prescribed anticholinergic agents such as benztropine, procyclidine, biperiden and trihexyphenidyl for treatment and prophylaxis of antipsychotic-induced extrapyramidal symptoms (EPS) for decades.

Schizophrenia is a complex, chronic mental health disorder characterized by an array of symptoms, including delusions, hallucinations, disorganized speech or behavior, and impaired cognitive ability.

2024年7月3日 · Medication is often a part of schizophrenia management, helping relieve symptoms related to psychosis, cognitive impairment, mood, and extrapyramidal symptoms. Schizophrenia is a lifelong mental...

2020年8月31日 · WASHINGTON, D.C., Sept. 1, 2020 – The American Psychiatric Association (APA) today released a new evidence-based practice guideline to enhance the treatment of patients with schizophrenia. Its goals are to reduce the mortality, morbidity and significant psychosocial and health consequences of this psychiatric condition.

2022年4月6日 · in a patient with schizophrenia should be a close review of medications, and avoidance of agents with anticholinergic properties.5 Prescribing benztropine for EPS EPS, which include dystonia, akathisia, drug­induced parkinsonism, and TD, are very frequent adverse effects noted with antipsychotics. Benztropine has demon­

To date, four studies have addressed the effects of discontinuation of anticholinergics on cognitive function in schizophrenia. 56 - 59 Baker et al. 56 reported that discontinuation of benztropine mesylate improved attention and concentration in patients with chronic schizophrenia.

2020年9月1日 · APA recommends (1B) that patients with schizophrenia be treated with cognitive-behavioral therapy for psychosis (CBTp).*

2024年2月13日 · The use of benztropine in patients with psychosis such as schizophrenia poses the risk of increasing their psychotic symptoms and behavioral changes. Anti-parkinsonian drugs can lead to toxic psychosis.